Authors:
MATTHAY KK
PEREZ C
SEEGER RC
BRODEUR GM
SHIMADA H
ATKINSON JB
BLACK CT
GERBING R
HAASE GM
STRAM DO
SWIFT P
LUKENS JN
Citation: Kk. Matthay et al., SUCCESSFUL TREATMENT OF STAGE-III NEUROBLASTOMA BASED ON PROSPECTIVE BIOLOGIC STAGING - A CHILDRENS CANCER GROUP-STUDY, Journal of clinical oncology, 16(4), 1998, pp. 1256-1264
Citation: Do. Stram et Mc. Pike, RE - ASSOCIATIONS OF RACE ETHNICITY, EDUCATION, AND DIETARY INTERVENTION WITH THE VALIDITY AND RELIABILITY OF A FOOD FREQUENCY QUESTIONNAIRE - THE WOMENS HEALTH TRIAL FEASIBILITY STUDY IN MINORITY POPULATIONS/, American journal of epidemiology, 148(8), 1998, pp. 819-820
Authors:
DEROOS AJ
OLSHAN AF
TESCHKE K
NEGLIA JP
STRAM DO
CASTLEBERRY RP
POLLOCK BH
Citation: Aj. Deroos et al., PARENTAL OCCUPATION AND THE RISK OF NEUROBLASTOMA IN OFFSPRING - A CASE-CONTROL STUDY, American journal of epidemiology, 147(11), 1998, pp. 341-341
Authors:
OPERSKALSKI EA
MOSLEY JW
BUSCH MP
STRAM DO
Citation: Ea. Operskalski et al., INFLUENCES OF AGE, VIRAL LOAD, AND CD4(-1 INFECTION TO AIDS() COUNT ON THE RATE OF PROGRESSION OF HIV), Journal of acquired immune deficiency syndromes and human retrovirology, 15(3), 1997, pp. 243-244
Authors:
OPERSKALSKI EA
BUSCH MP
MOSLEY JW
STRAM DO
Citation: Ea. Operskalski et al., COMPARATIVE RATES OF DISEASE PROGRESSION AMONG PERSONS INFECTED WITH THE SAME OR DIFFERENT HIV-1 STRAINS, Journal of acquired immune deficiency syndromes and human retrovirology, 15(2), 1997, pp. 145-150
Authors:
PETERS J
SEEGER RC
CAI B
YAO D
HONG CM
LUKENS J
MATTHAY KK
STRAM DO
SHIMADA H
Citation: J. Peters et al., QUANTITATION OF TRK-A MESSENGER-RNA BY RT-PCR IDENTIFIES BIOLOGICALLYAND CLINICALLY DISTINCT SUBSETS OF NEUROBLASTOMA, European journal of cancer, 33(12), 1997, pp. 2139-2139
Citation: Y. Khakoo et al., NEUROLOGICAL OUTCOME IN CHILDREN WITH OPSOCLONUS-MYOCLONUS-ATAXIA SYNDROME AND NEUROBLASTOMA - A REPORT FROM THE CHILDRENS CANCER GROUP, Annals of neurology, 42(3), 1997, pp. 27-27
Authors:
ANTUNES NL
KHAKOO Y
STRAM DO
SEEGER RC
MATTHAY KK
DALMAU J
Citation: Nl. Antunes et al., ANTINEURONAL ANTIBODIES IN PATIENTS WITH NEUROBLASTOMA AND PARANEOPLASTIC OPSOCLONUS-MYOCLONUS, Annals of neurology, 42(3), 1997, pp. 128-128
Authors:
OPERSKALSKI EA
STRAM DO
BUSCH MP
HUANG W
HARRIS M
DIETRICH SL
SCHIFF ER
DONEGAN E
MOSLEY JW
Citation: Ea. Operskalski et al., ROLE OF VIRAL LOAD IN HETEROSEXUAL TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY BLOOD-TRANSFUSION RECIPIENTS, American journal of epidemiology, 146(8), 1997, pp. 655-661
Authors:
LONGNECKER MP
STRAM DO
TAYLOR PR
LEVANDER OA
HOWE M
VEILLON C
MCADAM PA
PATTERSON KY
HOLDEN JM
MORRIS JS
SWANSON CA
WILLETT WC
Citation: Mp. Longnecker et al., USE OF SELENIUM CONCENTRATION IN WHOLE-BLOOD, SERUM, TOENAILS, OR URINE AS A SURROGATE MEASURE OF SELENIUM INTAKE, Epidemiology, 7(4), 1996, pp. 384-390
Authors:
STRAM DO
MATTHAY KK
OLEARY M
REYNOLDS CP
HAASE GM
ATKINSON JB
BRODEUR GM
SEEGER RC
Citation: Do. Stram et al., CONSOLIDATION CHEMORADIOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION VERSUS CONTINUED CHEMOTHERAPY FOR METASTATIC NEUROBLASTOMA - A REPORT OF 2 CONCURRENT CHILDRENS CANCER GROUP STUDIES, Journal of clinical oncology, 14(9), 1996, pp. 2417-2426
Authors:
MOSLEY JW
HUANG W
STRAM DO
NOWICKI MJ
HOLLINGER FB
AACH RD
STEVENS CE
BARBOSA LH
NEMO GJ
Citation: Jw. Mosley et al., DONOR LEVELS OF SERUM ALANINE AMINOTRANSFERASE ACTIVITY AND ANTIBODY TO HEPATITIS-B CORE ANTIGEN ASSOCIATED WITH RECIPIENT HEPATITIS-C AND NON-B,NON-C OUTCOMES, Transfusion, 36(9), 1996, pp. 776-781
Authors:
BUSCH MP
OPERSKALSKI EA
MOSLEY JW
LEE TH
HENRARD D
HERMAN S
SACHS DH
HARRIS M
HUANG W
STRAM DO
Citation: Mp. Busch et al., FACTORS INFLUENCING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TRANSMISSION BY BLOOD-TRANSFUSION, The Journal of infectious diseases, 174(1), 1996, pp. 26-33
Citation: Do. Stram et al., ANALYSIS OF TIME TO DEATH AFTER TRANSPLANTATION WHEN TRANSPLANTS ARE ONLY GIVEN TO PATIENTS IN REMISSION, Biometrics, 52(3), 1996, pp. 1079-1086
Citation: H. Lee et Do. Stram, SEGREGATION ANALYSIS OF CONTINUOUS PHENOTYPES BY USING HIGHER SAMPLE-MOMENTS, American journal of human genetics, 58(1), 1996, pp. 213-224
Authors:
SHIMADA H
STRAM DO
CHATTEN J
JOSHI VV
HACHITANDA Y
BRODEUR GM
LUKENS JN
MATTHAY KK
SEEGER RC
Citation: H. Shimada et al., IDENTIFICATION OF SUBSETS OF NEUROBLASTOMAS BY COMBINED HISTOPATHOLOGIC AND N-MYC ANALYSIS, Journal of the National Cancer Institute, 87(19), 1995, pp. 1470-1476
Authors:
HAASE GM
OLEARY MC
STRAM DO
LUKENS JN
SEEGER RC
SHIMADA H
MATTHAY KK
Citation: Gm. Haase et al., PELVIC NEUROBLASTOMA-IMPLICATIONS FOR A NEW FAVORABLE SUBGROUP - A CHILDRENS CANCER GROUP EXPERIENCE, Annals of surgical oncology, 2(6), 1995, pp. 516-523
Authors:
MATTHAY KK
OLEARY MC
RAMSAY NK
VILLABLANCA J
REYNOLDS CP
ATKINSON JB
HAASE GM
STRAM DO
SEEGER RC
Citation: Kk. Matthay et al., ROLE OF MYELOABLATIVE THERAPY IN IMPROVED OUTCOME FOR HIGH-RISK NEUROBLASTOMA - REVIEW OF RECENT CHILDRENS CANCER GROUP RESULTS, European journal of cancer, 31A(4), 1995, pp. 572-575
Authors:
HAASE GM
ATKINSON JB
STRAM DO
LUKENS JN
MATTHAY KK
Citation: Gm. Haase et al., SURGICAL-MANAGEMENT AND OUTCOME OF LOCOREGIONAL NEUROBLASTOMA - COMPARISON OF THE CHILDRENS CANCER GROUP AND THE INTERNATIONAL STAGING SYSTEMS, Journal of pediatric surgery, 30(2), 1995, pp. 289-295
Authors:
OPERSKALSKI EA
STRAM DO
LEE H
ZHOU Y
DONEGAN E
BUSCH MP
STEVENS CE
SCHIFF ER
DIETRICH SL
MOSLEY JW
Citation: Ea. Operskalski et al., HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION - RELATIONSHIP OF RISK GROUP AND AGE TO RATE OF PROGRESSION TO AIDS, The Journal of infectious diseases, 172(3), 1995, pp. 648-655
Citation: Do. Stram et Jw. Lee, VARIANCE COMPONENT TESTING IN THE LONGITUDINAL MIXED EFFECTS MODEL (VOL 50, PG 1171, 1994), Biometrics, 51(3), 1995, pp. 1196-1196